EB 1st Global Congress on Epidermolysis Bullosa This ground-breaking meeting will, for the first time, bring together all global knowledge in EB research, . Prevención de Ampollas. Como cargar al bebé: Evite levantar el bebé o niño por debajo de los brazos. En su lugar, ponga una mano debajo del trasero y la otra. Epidermolisis Bullosa distrófica (Niños mariposa) Es una enfermedad caracterizada por la fragilidad de la piel y las mucosas. Quienes la padecen poseen una.
|Published (Last):||27 July 2014|
|PDF File Size:||2.65 Mb|
|ePub File Size:||11.24 Mb|
|Price:||Free* [*Free Regsitration Required]|
Clinical trials The European Union Clinical Trials Register allows you to search for protocol and results information on: Cancer AND drug name. Pneumonia AND sponsor name.
EB-CLINET News Publication about Clinical Trial and Upcoming EB Events
How to search [pdf]. For these items you should use the filters and not add them to your search terms in the text field.
Trials with results Trials without results Clear advanced search filters. Review by the Competent Authority or Ethics Committee in the country concerned. EU Clinical Trials Register. Both Female Only Male Only.
IMP with orphan designation in the indication.
Epidermolysis bullosa – Wikipedia
Trials with results Trials without results. Clear advanced search filters. Date on which this record was first entered in the EudraCT database:.
Title of epudermolisis trial for lay people, in easily understood, i. A Clinical Trial which compare the safety and efficacy of a wound gel, the study treatment, or a sunflower oil-based vehicle gel in patients with Inherited Epidermolysis Bullosa EB. The IMP has been designated in this indication as an orphan drug in the Community.
Committee on Advanced therapies CAT has issued a classification for this product. Combination product that includes a device, but does not involve an Advanced Therapy. Illness called Bhllosa bullosa EB that makes skin blister and have open sores and wounds.
The primary objective of the double-blind phase is to compare the efficacy of Oleogel-S10 treatment arm A with vehicle treatment arm B in the promotion of healing of EB partial thickness wounds.
A patient will be eligible for study participation only epidermoilsis all of the following criteria apply: Patients with an EB target wound i.
epidermolisjs A patient will not be eligible to participate in this study if any of the following criteria apply: EB target wound with clinical signs of local infection 2. Use of systemic antibiotics for wound-related infections within 7 days prior to enrolment 3. Administration of systemic or topical steroids except for inhaled, ophthalmic or topical applications, such as budesonide suspension for oesophageal strictures [e.
Immunosuppressive therapy or cytotoxic chemotherapy within 60 days prior to enrolment 5. Patient has undergone stem cell transplant or gene therapy for the treatment of inherited EB 6. Enrolment in any interventional study or treated with any investigational drug for any disease within 4 weeks prior to study entry 8.
Patient lives in the same household as a study participant. The trial involves single site in the Member State concerned. Definition of the end of the trial and justification where it is not the last visit of the last subject undergoing the trial.
Plans for treatment or care after the subject has ended the participation in the trial if it is different from the expected normal treatment of that condition.